Liontrust Investment Partners’s Boston Scientific BSX Stock Holding History

Liontrust Investment Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-98,662	Closed	-$6.19M	–	197
2026 Q1	$6.19M	Sell	98,662 -21,858	-18%	-$1.75M	0.11%	112
2025 Q4	$11.5M	Buy	+120,520	New	+$11.8M	0.17%	98
2024 Q1	–	Sell	-70,703	Closed	-$4.09M	–	198
2023 Q4	$4.09M	Sell	70,703 -2,694	-4%	-$144K	0.06%	125
2023 Q3	$3.88M	Buy	73,397 +55,595	+312%	+$2.92M	0.06%	123
2023 Q2	$963K	Sell	17,802 -2,223	-11%	-$116K	0.01%	193
2023 Q1	$1M	Buy	+20,025	New	+$944K	0.01%	178

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Liontrust Investment Partners's BSX Position: Q2 2026 in Review

Liontrust Investment Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 98,662 shares — an estimated $6.19M sold.

Liontrust Investment Partners first reported a position in BSX in Q1 2023 and held it in 6 quarters. The position peaked at $11.5M in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Liontrust Investment Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Liontrust Investment Partners sold 98,662 Boston Scientific shares in Q2 2026, an estimated $6.19M.
Liontrust Investment Partners first reported a position in Boston Scientific in Q1 2023 and held it in 6 quarters.
Liontrust Investment Partners's Boston Scientific position peaked at $11.5M in Q4 2025.
1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Liontrust Investment Partners's 13F filing for Q2 2026, filed 18 Aug 2026.